Plasmagen Biosciences Private Limited, a active private limited company, was established on 07 September 2010 in Bangalore, Karnataka, India. Engaging in wholesale within the trade sector, it holds CIN: U51909KA2010PTC055077. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹114.85 Cr and a paid-up capital of ₹114.34 Cr.
It upholds a compliant status. Employing 262 professional, Its leadership includes Robert Mark Weisskoff (Director), Prem Venkatachalam Pavoor (Director), Gopal Sarda (Director). Past directors included Kapil Kumar Bhawarlal Jain, Robert Mark Weisskoff, Prem Venkatachalam Pavoor. It holds ₹305.25 Cr open charges and ₹20.55 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 160, Kci Chambers, 2Nd Floor, 5Th Main Road, Chamarajpet, Bangalore, Karnataka, 560018.
U51909KA2010PTC055077
055077
07 September 2010
₹114.85 Cr
₹114.34 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Plasmagen Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Robert Mark Weisskoff | Director | 28 Jul 2017 | Current |
| Prem Venkatachalam Pavoor | Director | 28 Jul 2017 | Current |
| Gopal Sarda | Director | 07 Jul 2017 | Current |
| Rahul Jain | Director | 07 Jul 2017 | Current |
| Vinod Nahar | Managing Director | 07 Sep 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 28 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 28 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 08 Jul 2017 | Past |
| Pramod Abcsdd | Director | 01 Jul 2017 | Past |
| Pramod Abcsdd | Director | 07 Jul 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Plasmagen Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.98% increase. The company also saw a substantial fall in profitability, with a 298.3% decrease in profit. The company's net worth Soared by an impressive increase of 57.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Plasmagen Biosciences had a promoter holding of 79.45% and a public holding of 20.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,052,524,000.00
₹205,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2025 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 29 Mar 2025 | Others | ₹30.00 Cr | Open |
| 06 Sep 2024 | Sbicap Trustee Company Limited | ₹45.00 Cr | Open |
| 22 Jun 2022 | Hdfc Bank Limited | ₹20.00 Cr | Open |
| 31 Mar 2022 | Others | ₹2.52 M | Open |
Explore comprehensive loan charge details -
Plasmagen Biosciences has a workforce of 262 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Plasmagen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plasmagen Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Plasmagen Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Arnav Jain was appointed as a Cfo was appointed as a Cfo on 26 Jun 2025 & has been associated with this company since 6 months 25 days . was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 101115155 was registered on 17 Jun 2025. was documented.
Plasmagen Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101128994 was registered on 29 Mar 2025. was documented.
The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 45.00 Cr with Charge ID 100970548 was registered on 06 Sep 2024. was completed.
The CIN of Plasmagen Biosciences Private Limited is U51909KA2010PTC055077.
Plasmagen Biosciences Private Limited is headquartered at No. 160, Kci Chambers, 2Nd Floor, 5Th Main Road, Chamarajpet, Bangalore, Karnataka, 560018.
Plasmagen Biosciences Private Limited was incorporated on 07 September 2010.
The current directors of Plasmagen Biosciences Private Limited are
The primary industry of Plasmagen Biosciences Private Limited is Trade.
Plasmagen Biosciences Private Limited is unlisted.
The authorized capital of Plasmagen Biosciences Private Limited is ₹114.85 Cr, and the paid-up capital is ₹114.34 Cr.
The compliance status of Plasmagen Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX